GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

WellQuest Medical & Wellness WEQL · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

At a glance

Figures in USD, from our data supplier.

FY2016

Revenue

$5.4m

FY2014FY2016

Net income

−$436,129

FY2014FY2016

Free cash flow

−$18,180

FY2014FY2016

Shareholders' equity

−$2.3m

FY2014FY2016

Income statement

Fiscal years

FY2016FY2015FY2014
Revenue$5.4m$6.1m$5.3m
Gross profit$448,327$500,655$151,473
Operating income−$339,035−$367,677−$420,614
Net income−$436,129−$423,413−$331,533
Diluted earnings per share-0.01-0.01-0.01

Balance sheet

At each fiscal year end

FY2016FY2015FY2014
Total assets$3.1m$3.2m$3.6m
Cash and short-term investments$21,164$23,401$14,589
Total liabilities$5.6m$5.1m$4.8m
Debt$3.9m$3.9m$3.8m
Shareholders' equity−$2.3m−$1.8m−$1.4m
Shares outstanding31m36m36m

Cash flow

Fiscal years

FY2016FY2015FY2014
Cash from operations$38,474−$34,899−$800,565
Capital spending−$56,654−$76,121−$43,895
Free cash flow−$18,180−$111,020−$844,460

Latest quarters

By quarter end

Sept 2017Jun 2017Mar 2017Dec 2016Dec 2015Sept 2015Jun 2015Mar 2015
Revenue$718,113$1.2m$1.4m$1.3m$1.6m$1.4m$1.4m$1.6m
Gross profit−$131,206$186,718$231,036$665,169$853,800$659,700$745,200$787,600
Operating income−$303,773−$6,153$23,732−$37,555−$53,800−$160,100−$111,700−$42,100
Net income−$260,795−$27,873−$13,854−$96,754−$83,500−$182,000−$136,300−$79,800
Diluted earnings per share-0.01-0.00-0.00-0.00-0.00-0.01-0.00-0.00
Total assets$2.9m$3.2m$3.2m$3.1m$3.3m$3.3m$3.4m$3.6m
Cash and short-term investments$14,956$22,385$23,407—$23,400$40,000$17,500$73,200
Debt$3.9m$3.9m$3.9m$3.9m$1.2m$1.2m$1.2m$1.2m
Shareholders' equity−$2.7m−$2.4m−$2.4m−$2.3m−$1.8m−$1.8m−$1.6m−$1.4m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue7.9%6.1%12.9%
Operating income-5.1%—-7.5%
Net income11.1%104.0%-6.8%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin8.3%5.8%9.2%11.2%
Operating margin-6.2%-7.2%-4.3%-6.7%
Net margin-7.5%-7.2%-2.2%-7.8%

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return0%0%0%-97%26809%2167%2390%1713%597%139%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.